HUGE -- Oversold COVID-19 play; insiders buying at premium
I am in at $2.35.
- Oversold, RSI @ 21
- $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results
- Will need to maintain $4+ stock price to stay listed on NASDAQ
- Gaps above at 3.33 & 5.56
- Signs of bottoming out
-
25M in cash; with Cannabis asset sale (~20M), the cash position will exceed market cap
- Due for COVID-19 treatment Phase 2 trial results within a week or two
- Oversold, RSI @ 21
- $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results
- Will need to maintain $4+ stock price to stay listed on NASDAQ
- Gaps above at 3.33 & 5.56
- Signs of bottoming out
-
25M in cash; with Cannabis asset sale (~20M), the cash position will exceed market cap- Due for COVID-19 treatment Phase 2 trial results within a week or two
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.